Medical Program: Keys to Accurate Diagnostic Staging for NSCLC

Be part of the knowledge.

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Keys to Accurate Diagnostic Staging for NSCLC

Program Information
Keys to Accurate Diagnostic Staging for NSCLC
About half of all NSCLC patients may qualify for immunotherapy, and testing for these five biomarkers is an essential step in finding those patients.
  • Sponsored by

  • Overview

    Obtaining a tissue biopsy has always been the standard for reaching both early and late-stage non-small cell lung cancer (NSCLC) diagnoses, but that’s no longer the case for all stages. See for yourself how the paradigm has changed with Dr. Edward Kim, Chair of Solid Tumor Oncology and Investigational Therapeutics at Levine Cancer Institute.

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio


Programs 10/16/19

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.